549 related articles for article (PubMed ID: 22553494)
1. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2.
Lawler PR; Lawler J
Cold Spring Harb Perspect Med; 2012 May; 2(5):a006627. PubMed ID: 22553494
[TBL] [Abstract][Full Text] [Related]
2. Regulation of tumor angiogenesis by thrombospondin-1.
Ren B; Yee KO; Lawler J; Khosravi-Far R
Biochim Biophys Acta; 2006 Apr; 1765(2):178-88. PubMed ID: 16406676
[TBL] [Abstract][Full Text] [Related]
3. An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo.
Noh YH; Matsuda K; Hong YK; Kunstfeld R; Riccardi L; Koch M; Oura H; Dadras SS; Streit M; Detmar M
J Invest Dermatol; 2003 Dec; 121(6):1536-43. PubMed ID: 14675207
[TBL] [Abstract][Full Text] [Related]
4. Identification of TAX2 peptide as a new unpredicted anti-cancer agent.
Jeanne A; Sick E; Devy J; Floquet N; Belloy N; Theret L; Boulagnon-Rombi C; Diebold MD; Dauchez M; Martiny L; Schneider C; Dedieu S
Oncotarget; 2015 Jul; 6(20):17981-8000. PubMed ID: 26046793
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma.
Tanaka K; Sonoo H; Kurebayashi J; Nomura T; Ohkubo S; Yamamoto Y; Yamamoto S
Clin Cancer Res; 2002 May; 8(5):1125-31. PubMed ID: 12006528
[TBL] [Abstract][Full Text] [Related]
6. CD36-TSP-HRGP interactions in the regulation of angiogenesis.
Silverstein RL; Febbraio M
Curr Pharm Des; 2007; 13(35):3559-67. PubMed ID: 18220792
[TBL] [Abstract][Full Text] [Related]
7. CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo.
Koch M; Hussein F; Woeste A; Gründker C; Frontzek K; Emons G; Hawighorst T
Breast Cancer Res Treat; 2011 Jul; 128(2):337-46. PubMed ID: 20714802
[TBL] [Abstract][Full Text] [Related]
8. Identification of CD36 molecular features required for its in vitro angiostatic activity.
Primo L; Ferrandi C; Roca C; Marchiò S; di Blasio L; Alessio M; Bussolino F
FASEB J; 2005 Oct; 19(12):1713-5. PubMed ID: 16037098
[TBL] [Abstract][Full Text] [Related]
9. Novel antiangiogenic pathway of thrombospondin-1 mediated by suppression of the cell cycle.
Yamauchi M; Imajoh-Ohmi S; Shibuya M
Cancer Sci; 2007 Sep; 98(9):1491-7. PubMed ID: 17596205
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin-1 modulates VEGF-A-mediated Akt signaling and capillary survival in the developing retina.
Sun J; Hopkins BD; Tsujikawa K; Perruzzi C; Adini I; Swerlick R; Bornstein P; Lawler J; Benjamin LE
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1344-51. PubMed ID: 19304944
[TBL] [Abstract][Full Text] [Related]
11. Pterostilbene carboxaldehyde thiosemicarbazone, a resveratrol derivative inhibits 17β-Estradiol induced cell migration and proliferation in HUVECs.
Nikhil K; Sharan S; Wishard R; Palla SR; Krishna Peddinti R; Roy P
Steroids; 2016 Apr; 108():17-30. PubMed ID: 26850466
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondins in cancer.
Kazerounian S; Yee KO; Lawler J
Cell Mol Life Sci; 2008 Mar; 65(5):700-12. PubMed ID: 18193162
[TBL] [Abstract][Full Text] [Related]
13. Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level.
Zhang X; Kazerounian S; Duquette M; Perruzzi C; Nagy JA; Dvorak HF; Parangi S; Lawler J
FASEB J; 2009 Oct; 23(10):3368-76. PubMed ID: 19528255
[TBL] [Abstract][Full Text] [Related]
14. Tumor angiogenesis.
Detmar M
J Investig Dermatol Symp Proc; 2000 Dec; 5(1):20-3. PubMed ID: 11147670
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-4 mediates TGF-β-induced angiogenesis.
Muppala S; Xiao R; Krukovets I; Verbovetsky D; Yendamuri R; Habib N; Raman P; Plow E; Stenina-Adognravi O
Oncogene; 2017 Sep; 36(36):5189-5198. PubMed ID: 28481870
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-based antiangiogenic therapy.
Zhang X; Lawler J
Microvasc Res; 2007; 74(2-3):90-9. PubMed ID: 17559888
[TBL] [Abstract][Full Text] [Related]
17. Capillary sprout endothelial cells exhibit a CD36 low phenotype: regulation by shear stress and vascular endothelial growth factor-induced mechanism for attenuating anti-proliferative thrombospondin-1 signaling.
Anderson CR; Hastings NE; Blackman BR; Price RJ
Am J Pathol; 2008 Oct; 173(4):1220-8. PubMed ID: 18772338
[TBL] [Abstract][Full Text] [Related]
18. Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis.
Cursiefen C; Masli S; Ng TF; Dana MR; Bornstein P; Lawler J; Streilein JW
Invest Ophthalmol Vis Sci; 2004 Apr; 45(4):1117-24. PubMed ID: 15037577
[TBL] [Abstract][Full Text] [Related]
19. Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology.
Helkin A; Maier KG; Gahtan V
Biochem Biophys Res Commun; 2015 Sep; 464(4):1022-1027. PubMed ID: 26168731
[TBL] [Abstract][Full Text] [Related]
20. Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase.
Kazerounian S; Duquette M; Reyes MA; Lawler JT; Song K; Perruzzi C; Primo L; Khosravi-Far R; Bussolino F; Rabinovitz I; Lawler J
Blood; 2011 Apr; 117(17):4658-66. PubMed ID: 21378271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
